JPS5418330B2
(cs)
*
|
1973-03-16 |
1979-07-06 |
|
|
US3966905A
(en)
*
|
1973-05-29 |
1976-06-29 |
Barnes-Hind Pharmaceuticals, Inc. |
Stabilized catechol amine solutions
|
US3929989A
(en)
*
|
1974-06-14 |
1975-12-30 |
Wendt Lab Inc |
Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
|
GB1538903A
(en)
*
|
1975-04-11 |
1979-01-24 |
Nelson Res & Dev |
Carrier for a topically applied physiologically active agent or cosmetic agent
|
US4018889A
(en)
*
|
1976-01-02 |
1977-04-19 |
Pfizer Inc. |
Oxytetracycline compositions
|
DE2602363C2
(de)
*
|
1976-01-22 |
1984-04-12 |
Bayer Ag, 5090 Leverkusen |
Wäßrige, injizierbare Niclofolan- Formulierungen
|
GB1592053A
(en)
*
|
1976-12-16 |
1981-07-01 |
Norbrook Lab Ltd |
Oxytetracycline compositions
|
US4213963A
(en)
*
|
1978-12-14 |
1980-07-22 |
Janssen Pharmaceutica N.V. |
Fluspirilene-containing compositions
|
US4259331A
(en)
*
|
1979-04-16 |
1981-03-31 |
Pfizer Inc. |
Oxytetracycline compositions
|
US4386083A
(en)
*
|
1980-04-10 |
1983-05-31 |
Walter Hacke |
Injectable oxytetracycline compositions
|
US4399127A
(en)
*
|
1980-04-10 |
1983-08-16 |
Diamond Shamrock Corporation |
Injectable oxytetracycline compositions
|
IE74244B1
(en)
*
|
1985-10-01 |
1997-07-16 |
Bimeda Res Dev Ltd |
A process for preparing an antibiotic composition
|
US5071643A
(en)
*
|
1986-10-17 |
1991-12-10 |
R. P. Scherer Corporation |
Solvent system enhancing the solubility of pharmaceuticals for encapsulation
|
US6756365B2
(en)
*
|
1991-11-06 |
2004-06-29 |
Trustees Of Tufts College |
Reducing tetracycline resistance in living cells
|
EP0626171A1
(de)
*
|
1993-05-26 |
1994-11-30 |
Winfried Dörnhöfer |
Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
|
US6383515B2
(en)
|
1999-05-28 |
2002-05-07 |
Sawyer Maryjean |
Solvent system for enhancing solubility
|
US8106225B2
(en)
*
|
1999-09-14 |
2012-01-31 |
Trustees Of Tufts College |
Methods of preparing substituted tetracyclines with transition metal-based chemistries
|
US6849615B2
(en)
|
1999-09-14 |
2005-02-01 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
US6500812B2
(en)
|
1999-09-14 |
2002-12-31 |
Paratek Pharmaceuticals, Inc. |
13-substituted methacycline compounds
|
EP2327686A3
(en)
|
1999-09-14 |
2012-08-22 |
Trustees Of Tufts College |
Methods of preparing substituted tetracyclines with transition metal-based chemistries
|
JP2003523963A
(ja)
*
|
2000-01-24 |
2003-08-12 |
トラスティーズ・オブ・タフツ・カレッジ |
クリプトスポリジウム・パルヴム関連疾患の治療のためのテトラサイクリン化合物
|
ES2288945T3
(es)
*
|
2000-03-31 |
2008-02-01 |
Trustees Of Tufts College |
Compuestos de tetraciclina 7 y 9-carbamato, urea, tiourea, tiocarbamato y heteroaril-amino sustituidos.
|
EP1286954B1
(en)
*
|
2000-05-15 |
2004-04-14 |
Paratek Pharmaceuticals, Inc. |
7-substituted fused ring tetracycline compounds
|
US20020132798A1
(en)
*
|
2000-06-16 |
2002-09-19 |
Nelson Mark L. |
7-phenyl-substituted tetracycline compounds
|
AU2001268475A1
(en)
*
|
2000-06-16 |
2002-01-02 |
Trustees Of Tufts College |
7-phenyl-substituted tetracycline compounds
|
US20040224927A1
(en)
*
|
2000-06-16 |
2004-11-11 |
Trustees Of Tufts College |
7-N-substituted phenyl tetracycline compounds
|
JP4963771B2
(ja)
|
2000-07-07 |
2012-06-27 |
トラスティーズ・オブ・タフツ・カレッジ |
7、8および9−置換テトラサイクリン化合物
|
KR101083571B1
(ko)
|
2000-07-07 |
2011-11-14 |
파라테크 파마슈티컬스, 인크. |
7-치환 테트라사이클린 화합물
|
AU2001271616A1
(en)
|
2000-07-07 |
2002-01-21 |
Paratek Pharmaceuticals, Inc |
13-substituted methacycline compounds
|
EP2308832B8
(en)
*
|
2000-07-07 |
2019-04-24 |
Trustees Of Tufts College |
9-substituted minocycline compounds
|
US7094806B2
(en)
*
|
2000-07-07 |
2006-08-22 |
Trustees Of Tufts College |
7, 8 and 9-substituted tetracycline compounds
|
US20050143353A1
(en)
*
|
2000-07-07 |
2005-06-30 |
Paratek Pharmaceuticals, Inc. |
13-Substituted methacycline compounds
|
EA201000388A1
(ru)
|
2001-03-13 |
2010-10-29 |
Пэрэтек Фамэсьютикэлс, Инк. |
Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта
|
WO2002072506A2
(en)
*
|
2001-03-13 |
2002-09-19 |
Paratek Pharmaceuticals, Inc. |
7-pyrollyl tetracycline compounds and methods of use thereof
|
CA2457234A1
(en)
|
2001-03-14 |
2002-09-19 |
Mark L. Nelson |
Substituted tetracycline compounds as antifungal agents
|
EP1381372A2
(en)
|
2001-03-14 |
2004-01-21 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds as synergistic antifungal agents
|
AU2002254714C1
(en)
|
2001-04-24 |
2010-01-07 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
US8088820B2
(en)
*
|
2001-04-24 |
2012-01-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for the treatment of malaria
|
EP2311797A1
(en)
|
2002-01-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
4-dedimethylamino tetracycline compounds
|
JP2005526754A
(ja)
|
2002-03-08 |
2005-09-08 |
パラテック ファーマシューティカルズ インコーポレイテッド |
アミノメチル置換されたテトラサイクリン化合物
|
CN1653037A
(zh)
|
2002-03-21 |
2005-08-10 |
帕拉特克药品公司 |
取代的四环素化合物
|
EP2345637A3
(en)
|
2002-07-12 |
2012-02-15 |
Paratek Pharmaceuticals, Inc. |
3, 10, and 12a substituted tetracycline compounds
|
EP1556007A4
(en)
|
2002-10-24 |
2008-12-17 |
Paratek Pharm Innc |
SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA
|
JP2006514119A
(ja)
*
|
2003-02-12 |
2006-04-27 |
アール アンド ピー コリア カンパニー リミテッド |
溶解率が向上した難溶性薬剤の溶媒系
|
WO2005009943A2
(en)
|
2003-07-09 |
2005-02-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
US20060287283A1
(en)
*
|
2003-07-09 |
2006-12-21 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
US20050137174A1
(en)
|
2003-07-09 |
2005-06-23 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
EP1716101A1
(en)
*
|
2004-01-15 |
2006-11-02 |
Paratek Pharmaceuticals, Inc. |
Aromatic a-ring derivatives of tetracycline compounds
|
TWI261038B
(en)
*
|
2004-08-11 |
2006-09-01 |
Bo-Cheng Chen |
Bicycle gear-shifting handgrip
|
EP2284152A3
(en)
|
2004-10-25 |
2011-10-05 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
EP2301912A3
(en)
|
2004-10-25 |
2012-07-11 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines and methods of use thereof
|
US8088755B2
(en)
*
|
2005-02-04 |
2012-01-03 |
Paratek Pharmaceuticals, Inc. |
11a, 12-derivatives of tetracycline compounds
|
DE102005012595A1
(de)
*
|
2005-03-18 |
2006-09-21 |
Lanxess Deutschland Gmbh |
Herstellung von Tri(chlorpropyl)phosphat
|
JP2009502809A
(ja)
*
|
2005-07-21 |
2009-01-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
10−置換テトラサイクリンおよびその使用方法
|
US20080269334A1
(en)
*
|
2005-09-19 |
2008-10-30 |
Albemarle Corporation |
Highly Concentrated Pourable Aqueous Solutions Of Potassium Ibuprofen, Their Preparation And Their Use
|
WO2007087416A2
(en)
*
|
2006-01-24 |
2007-08-02 |
Paratek Pharaceuticals, Inc. |
Methods of increasing oral bioavailability of tetracyclines
|
WO2007120913A2
(en)
*
|
2006-04-17 |
2007-10-25 |
Teva Pharmaceutical Industries Ltd. |
Isolation of tetracycline derivatives
|
US8198470B2
(en)
*
|
2006-04-24 |
2012-06-12 |
Teva Pharmaceutical Industries Ltd. |
Crystalline form II of tigecycline and processes for preparation thereof
|
PL2016045T3
(pl)
*
|
2006-04-24 |
2015-04-30 |
Teva Pharma |
Krystaliczna postać tygecykliny i sposoby jej otrzymywania
|
EP2026776A2
(en)
*
|
2006-05-15 |
2009-02-25 |
Paratek Pharmaceuticals, Inc. |
Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
|
WO2008045507A2
(en)
|
2006-10-11 |
2008-04-17 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of bacillus anthracis infections
|
US8513223B2
(en)
|
2006-12-21 |
2013-08-20 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of inflammatory skin disorders
|
MX2009006846A
(es)
|
2006-12-21 |
2009-08-20 |
Paratek Pharm Innc |
Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
|
CA2688725A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Paratek Pharmaceuticals, Inc. |
Methods for treating spinal muscular atrophy using tetracycline compounds
|
US9434680B2
(en)
*
|
2007-04-27 |
2016-09-06 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing and purifying aminoalkyl tetracycline compounds
|
CN101784517A
(zh)
|
2007-07-06 |
2010-07-21 |
帕拉特克药品公司 |
合成取代的四环素化合物的方法
|
BRPI0908951A2
(pt)
|
2008-03-05 |
2017-01-17 |
Paratek Pharm Innc |
compostos de minociclina e método de uso dos mesmos
|
PT2271348T
(pt)
|
2008-03-28 |
2018-04-16 |
Paratek Pharm Innc |
Formulação de comprimido oral de composto de tetraciclina
|
CA2721399A1
(en)
*
|
2008-04-14 |
2009-10-22 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
TW202332671A
(zh)
|
2008-05-19 |
2023-08-16 |
美商Prtk Spv2公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
US9629809B2
(en)
|
2008-07-21 |
2017-04-25 |
Si Group, Inc. |
High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
|
CN102099017A
(zh)
|
2008-07-21 |
2011-06-15 |
雅宝公司 |
高含量布洛芬钠颗粒、其制备及其在制备非泡腾固体剂型中的用途
|
MX2011002780A
(es)
*
|
2008-09-19 |
2011-04-27 |
Paratek Pharm Innc |
Compuestos de tetraciclina para el tratamiento de artritis reumatoide y metodos relacionados de tratamiento.
|
EP3061460A1
(en)
|
2009-04-10 |
2016-08-31 |
Tufts Medical Center, Inc. |
Par-1 activation by metalloproteinase-1 (mmp-1)
|
HRP20191295T8
(hr)
|
2011-05-12 |
2020-02-07 |
Paratek Pharmaceuticals, Inc. |
Kristalne soli amida (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksilne kiseline i postupci uporabe istih
|
BR112019008897A2
(pt)
|
2016-11-01 |
2019-08-13 |
Paratek Pharm Innc |
método para tratar pneumonia bacteriana adquirida na comunidade.
|
CN111343991A
(zh)
|
2017-07-21 |
2020-06-26 |
阿尔米雷尔有限责任公司 |
非炎性病变的治疗
|